(Q43681773)

English

GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Neisseria gonorrhoeae

0 references

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

3

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Deshpande LM

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Gales AC

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

29-35

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tetracyclines, molecular and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of antimicrobial resistance: changing epidemiology of community-acquired respiratory-tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of two glycylcyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disk diffusion susceptibility test development for the new glycylcycline, GAR-936

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900355-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(01)00355-7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43681773&oldid=2102477846"